CST3 and kidney cancer: However, for eGFRcys calculated based on cystatin C,49 our results did not suggest a significant genetic causal role on kidney cancer, while the reverse MR analysis might indicate that kidney cancer was likely to decrease kidney function via the shared genetic mechanism with eGFRcys.